Clostridium difficile infection in low- and middle-human development index countries: a systematic review

Joseph D. Forrester, Lawrence Z. Cai, Chenesa Mbanje, Tanya N. Rinderknecht, Sherry M. Wren

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

Objective: To describe the impact and epidemiology of Clostridium difficile infection (CDI) in low- and middle-human development index (LMHDI) countries. Method: Prospectively registered, systematic literature review of existing literature in the PubMed, Ovid and Web of Science databases describing the epidemiology and management of C. difficile in LMHDI countries. Risk factors were compared between studies when available. Results: Of the 218 abstracts identified after applying search criteria, 25 studies were reviewed in detail. The weighted pooled infection rate among symptomatic non-immunosuppressed inpatients was 15.8% (95% CI 12.1–19.5%) and was 10.1% (95% CI 3.0–17.2%) among symptomatic outpatients. Subgroup analysis of immunosuppressed patient populations revealed pooled infection rates similar to non-immunosuppressed patient populations. Risk factor analysis was infrequently performed. Conclusions: While the percentages of patients with CDI in LMHDI countries among the reviewed studies are lower than expected, there remains a paucity of epidemiologic data evaluating burden of C. difficile infection in these settings.

Original languageEnglish (US)
Pages (from-to)1223-1232
Number of pages10
JournalTropical Medicine and International Health
Volume22
Issue number10
DOIs
StatePublished - Oct 2017
Externally publishedYes

Fingerprint

Clostridium Infections
Clostridium difficile
Human Development
Epidemiology
Infection
PubMed
Population
Statistical Factor Analysis
Inpatients
Outpatients
Databases

Keywords

  • C. difficile infection
  • low- and middle-income countries
  • systematic review

ASJC Scopus subject areas

  • Parasitology
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

Clostridium difficile infection in low- and middle-human development index countries : a systematic review. / Forrester, Joseph D.; Cai, Lawrence Z.; Mbanje, Chenesa; Rinderknecht, Tanya N.; Wren, Sherry M.

In: Tropical Medicine and International Health, Vol. 22, No. 10, 10.2017, p. 1223-1232.

Research output: Contribution to journalReview article

Forrester, Joseph D. ; Cai, Lawrence Z. ; Mbanje, Chenesa ; Rinderknecht, Tanya N. ; Wren, Sherry M. / Clostridium difficile infection in low- and middle-human development index countries : a systematic review. In: Tropical Medicine and International Health. 2017 ; Vol. 22, No. 10. pp. 1223-1232.
@article{60279958ed384589ac2863b93a718bce,
title = "Clostridium difficile infection in low- and middle-human development index countries: a systematic review",
abstract = "Objective: To describe the impact and epidemiology of Clostridium difficile infection (CDI) in low- and middle-human development index (LMHDI) countries. Method: Prospectively registered, systematic literature review of existing literature in the PubMed, Ovid and Web of Science databases describing the epidemiology and management of C. difficile in LMHDI countries. Risk factors were compared between studies when available. Results: Of the 218 abstracts identified after applying search criteria, 25 studies were reviewed in detail. The weighted pooled infection rate among symptomatic non-immunosuppressed inpatients was 15.8{\%} (95{\%} CI 12.1–19.5{\%}) and was 10.1{\%} (95{\%} CI 3.0–17.2{\%}) among symptomatic outpatients. Subgroup analysis of immunosuppressed patient populations revealed pooled infection rates similar to non-immunosuppressed patient populations. Risk factor analysis was infrequently performed. Conclusions: While the percentages of patients with CDI in LMHDI countries among the reviewed studies are lower than expected, there remains a paucity of epidemiologic data evaluating burden of C. difficile infection in these settings.",
keywords = "C. difficile infection, low- and middle-income countries, systematic review",
author = "Forrester, {Joseph D.} and Cai, {Lawrence Z.} and Chenesa Mbanje and Rinderknecht, {Tanya N.} and Wren, {Sherry M.}",
year = "2017",
month = "10",
doi = "10.1111/tmi.12937",
language = "English (US)",
volume = "22",
pages = "1223--1232",
journal = "Tropical Medicine and International Health",
issn = "1360-2276",
publisher = "Wiley-Blackwell",
number = "10",

}

TY - JOUR

T1 - Clostridium difficile infection in low- and middle-human development index countries

T2 - a systematic review

AU - Forrester, Joseph D.

AU - Cai, Lawrence Z.

AU - Mbanje, Chenesa

AU - Rinderknecht, Tanya N.

AU - Wren, Sherry M.

PY - 2017/10

Y1 - 2017/10

N2 - Objective: To describe the impact and epidemiology of Clostridium difficile infection (CDI) in low- and middle-human development index (LMHDI) countries. Method: Prospectively registered, systematic literature review of existing literature in the PubMed, Ovid and Web of Science databases describing the epidemiology and management of C. difficile in LMHDI countries. Risk factors were compared between studies when available. Results: Of the 218 abstracts identified after applying search criteria, 25 studies were reviewed in detail. The weighted pooled infection rate among symptomatic non-immunosuppressed inpatients was 15.8% (95% CI 12.1–19.5%) and was 10.1% (95% CI 3.0–17.2%) among symptomatic outpatients. Subgroup analysis of immunosuppressed patient populations revealed pooled infection rates similar to non-immunosuppressed patient populations. Risk factor analysis was infrequently performed. Conclusions: While the percentages of patients with CDI in LMHDI countries among the reviewed studies are lower than expected, there remains a paucity of epidemiologic data evaluating burden of C. difficile infection in these settings.

AB - Objective: To describe the impact and epidemiology of Clostridium difficile infection (CDI) in low- and middle-human development index (LMHDI) countries. Method: Prospectively registered, systematic literature review of existing literature in the PubMed, Ovid and Web of Science databases describing the epidemiology and management of C. difficile in LMHDI countries. Risk factors were compared between studies when available. Results: Of the 218 abstracts identified after applying search criteria, 25 studies were reviewed in detail. The weighted pooled infection rate among symptomatic non-immunosuppressed inpatients was 15.8% (95% CI 12.1–19.5%) and was 10.1% (95% CI 3.0–17.2%) among symptomatic outpatients. Subgroup analysis of immunosuppressed patient populations revealed pooled infection rates similar to non-immunosuppressed patient populations. Risk factor analysis was infrequently performed. Conclusions: While the percentages of patients with CDI in LMHDI countries among the reviewed studies are lower than expected, there remains a paucity of epidemiologic data evaluating burden of C. difficile infection in these settings.

KW - C. difficile infection

KW - low- and middle-income countries

KW - systematic review

UR - http://www.scopus.com/inward/record.url?scp=85030642874&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030642874&partnerID=8YFLogxK

U2 - 10.1111/tmi.12937

DO - 10.1111/tmi.12937

M3 - Review article

C2 - 28796388

AN - SCOPUS:85030642874

VL - 22

SP - 1223

EP - 1232

JO - Tropical Medicine and International Health

JF - Tropical Medicine and International Health

SN - 1360-2276

IS - 10

ER -